GSK Investigational Site

Rialto, California 92337

We've found

1 trials

at this facility

Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)

Status: Enrolling, Phase II, III
Updated: 12/31/1969

from

Rialto, CA

Use our guide to learn which trials are right for you!